Monday said that the European Patent Office (EPO) has issued a notice of allowance for a composition of matter patent covering its drug candidate LP-284.

Madrigal Pharmaceuticals MDGL shares soared 10.9% on Wednesday. The uptrend was observed after the U.S. Patent and Trademark ...

World IP Review is set to host the highly anticipated AI and IP USA 2025, a one-day event on October 9, 2025 in New York. The ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Opinion: Knobbe Marten's Ted Cannon analyzes the sharp rise in denials of patent validity challenges at the Patent Trial and Appeal Board and explains why filing a petition promptly can help a ...

NEW YORK-- (BUSINESS WIRE)-- Patlytics, the AI-powered patent workflow platform, today announced the appointment of Michelle K. Lee as Senior Strategic Advisor. A pioneering and respected leader ...

You successfully represented Regeneron Pharmaceuticals Inc. in Regeneron Pharmaceuticals Inc. v. Mylan Pharmaceuticals, Inc., in which the US District Court for the Northern District of West Virginia ...

Samsung secures interim patent licence in UK court ruling against ZTE, a key step in a multi-country FRAND dispute over mobile technologies.